Author/Authors :
Athyros، نويسنده , , Vasilios G. and Papageorgiou، نويسنده , , Athanasios A. and Hatzikonstandinou، نويسنده , , Haris A. and Didangelos، نويسنده , , Triandafillos P. and Carina، نويسنده , , Maria V. and Kranitsas، نويسنده , , Dimitrios F. and Kontopoulos، نويسنده , , Athanasios G.، نويسنده ,
Abstract :
No monotherapy is able to tackle effectively all atherogenic features of familial combined hyperlipidemia: high low-density lipoprotein (LDL) cholesterol, triglycerides (TG), and plasma fibrinogen, as well as low high-density lipoprotein (HDL) cholesterol
